Product Information
LEVONOR-ETH ESTRAD TRIPHASIC is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.3395 per EA under NDC 68180085773. Its NADAC has been published 294 times since Jan 6, 2021.
FDA first approved this application on Nov 19, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180085773
Classification
Generic
Dosage Form
KIT
Effective Date
8/19/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA200248FDA Approved
11/19/2015
TE Code
AB
On Market Since
8/30/2020
Price Statistics
The NADAC for LEVONOR-ETH ESTRAD TRIPHASIC has been published 294 times since Jan 6, 2021, and over the history we have for it it has declined 27.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3395 per EA |
|---|---|
| All-time high | $0.5249 (Apr 14, 2021) |
| All-time low | $0.2138 (Jul 17, 2024) |
| 52-week high | $0.4387 |
| 52-week low | $0.2829 |
| Median price | $0.3530 |
| Average price | $0.3606 |
| Largest weekly change | +85.8% (Nov 22, 2023) |
| Weeks tracked | 294 |
| Tracking since | Jan 6, 2021 |
Generic Alternatives
The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 67% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LEVONOR-ETH ESTRAD TRIPHASIC?
The current National Average Drug Acquisition Cost (NADAC) for LEVONOR-ETH ESTRAD TRIPHASIC, manufactured by Lupin Pharmaceuticals Inc., is $0.3395 per EA (NDC 68180085773), effective Aug 19, 2026.
How has the price of LEVONOR-ETH ESTRAD TRIPHASIC changed over time?
Over the history we have for it, the NADAC for LEVONOR-ETH ESTRAD TRIPHASIC has declined 27.6%. It has been tracked across 294 weekly CMS publications since Jan 6, 2021.
What are the highest and lowest recorded NADAC prices for LEVONOR-ETH ESTRAD TRIPHASIC?
Since Jan 6, 2021, the NADAC for LEVONOR-ETH ESTRAD TRIPHASIC has ranged from a low of $0.2138 (Jul 17, 2024) to a high of $0.5249 (Apr 14, 2021), with a median of $0.3530 per EA.
Are there cheaper alternatives to LEVONOR-ETH ESTRAD TRIPHASIC?
Yes. 9 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CHATEAL EQ-28 TABLET, is $0.1128 per EA — about 67% below LEVONOR-ETH ESTRAD TRIPHASIC.
Who manufactures LEVONOR-ETH ESTRAD TRIPHASIC?
LEVONOR-ETH ESTRAD TRIPHASIC (NDC 68180085773) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.